De-Risk the Transition

The United States Pharmacopeia (USP) requirements for elastomeric components of container closure systems used for parenteral products are changing. The scope of USP <382> Elastomeric Component Functional Suitability in Parenteral Product Packaging/Delivery Systems1 introduces a paradigm shift away from testing elastomeric components individually by the supplier, as was done historically under USP <381> Elastomeric Components in Injectable Pharmaceutical Production Packaging/Delivery Systems,2 to a holistic evaluation of these components when assembled into drug product packaging and delivery systems.

Your Approach to USP <382> for Your Drug Product Packaging: Think Systems, Not Components

Download our free e-book for insight on ways to:

Read time :

4 minutes

Reduce Development and Supply Risk

Accelerate Your Path to Market

Navigate a regulatory landscape for combination products

Select the right components & system for your drug application

First Name

Last Name

Company Name

Work Email

Country

Captcha

Yes, I would like to receive email updates from West.

By providing your contact information and checking this box, you are consenting to the use of your personal data as described in our Privacy Policy, and assenting to the website Terms and Conditions of Use.

Your Approach to USP <382> for Your Drug Product Packaging: Think Systems, Not Components

Your Approach to USP <382> for Your Drug Product Packaging: Think Systems, Not Components

What can you do to minimize risk as you transition to a combination product?